But this is far from the first time the FDA has taken direct aim
at kratom under Gottlieb's tenure.
Not exact matches
Advocates for
kratom tend to argue that the FDA is protecting big pharmaceutical interests — or
at the very least isn't keeping an open mind — by cracking down on the product.
The FDA
kratom recall is aimed
at a company called Triangle Pharmanaturals LLC after some products from the company were found to contain salmonella, according to the agency.
But just like some of the new opioids that scientists are developing,
kratom's active ingredients appear — anecdotally,
at least — to deliver pain relief with fewer problems and less risk of tolerance.
Some chronic opioid users switch to
kratom to wean themselves off of pain pills and ease withdrawal symptoms, says Oliver Grundmann, a medicinal chemist
at the University of Florida in Gainesville.
Often used to help people with opioid addiction,
kratom (which can be bought online or in a vending machine) has caused
at least 36 deaths because the product is unregulated and being used without instruction.